Financial Counselors Inc. boosted its stake in Dow Chemical Company (The) (NYSE:DOW) by 2.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 172,958 shares of the basic materials company’s stock after buying an additional 4,856 shares during the period. Financial Counselors Inc.’s holdings in Dow Chemical Company (The) were worth $10,990,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Moody National Bank Trust Division increased its position in Dow Chemical Company (The) by 2.9% in the first quarter. Moody National Bank Trust Division now owns 22,839 shares of the basic materials company’s stock valued at $1,451,000 after buying an additional 633 shares during the period. City Holding Co. increased its position in Dow Chemical Company (The) by 1.3% in the first quarter. City Holding Co. now owns 6,386 shares of the basic materials company’s stock valued at $406,000 after buying an additional 81 shares during the period. Huntington National Bank increased its position in Dow Chemical Company (The) by 5.2% in the first quarter. Huntington National Bank now owns 710,022 shares of the basic materials company’s stock valued at $45,115,000 after buying an additional 35,316 shares during the period. State of Alaska Department of Revenue increased its position in Dow Chemical Company (The) by 8.8% in the first quarter. State of Alaska Department of Revenue now owns 98,946 shares of the basic materials company’s stock valued at $6,286,000 after buying an additional 7,986 shares during the period. Finally, Chelsea Counsel Co. purchased a new position in Dow Chemical Company (The) during the first quarter valued at about $200,000. 67.77% of the stock is owned by institutional investors and hedge funds.

Dow Chemical Company (NYSE DOW) remained flat at $66.65 during mid-day trading on Friday. The stock had a trading volume of 43,802,070 shares. Dow Chemical Company has a 1-year low of $51.57 and a 1-year high of $67.50. The firm has a market cap of $81.54 billion, a price-to-earnings ratio of 28.54 and a beta of 1.13. The stock’s 50 day moving average is $64.79 and its 200-day moving average is $63.46.

Dow Chemical Company (The) (NYSE:DOW) last announced its earnings results on Thursday, July 27th. The basic materials company reported $1.08 EPS for the quarter, beating the consensus estimate of $1.01 by $0.07. Dow Chemical Company (The) had a return on equity of 17.08% and a net margin of 5.83%. The business had revenue of $13.83 billion during the quarter, compared to the consensus estimate of $13.60 billion. During the same period in the prior year, the business posted $0.95 earnings per share. Dow Chemical Company (The)’s revenue was up 15.7% compared to the same quarter last year. On average, equities research analysts predict that Dow Chemical Company will post $4.08 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Monday, July 31st will be issued a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.76%. The ex-dividend date of this dividend is Thursday, July 27th. Dow Chemical Company (The)’s dividend payout ratio is 76.99%.

COPYRIGHT VIOLATION WARNING: “Financial Counselors Inc. Increases Stake in Dow Chemical Company (The) (DOW)” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/09/02/financial-counselors-inc-increases-stake-in-dow-chemical-company-the-dow.html.

DOW has been the subject of several research reports. UBS AG reaffirmed a “buy” rating and set a $72.00 price target on shares of Dow Chemical Company (The) in a research note on Monday, May 15th. Cowen and Company lifted their price target on Dow Chemical Company (The) from $47.00 to $60.00 and gave the stock a “market perform” rating in a research note on Wednesday, May 31st. BidaskClub raised Dow Chemical Company (The) from a “strong sell” rating to a “sell” rating in a research note on Saturday, July 1st. Zacks Investment Research downgraded Dow Chemical Company (The) from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $76.00 price target on shares of Dow Chemical Company (The) in a research note on Thursday, July 6th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Dow Chemical Company (The) has a consensus rating of “Buy” and a consensus target price of $71.42.

Dow Chemical Company (The) Company Profile

Want to see what other hedge funds are holding DOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dow Chemical Company (The) (NYSE:DOW).

Institutional Ownership by Quarter for Dow Chemical Company (The) (NYSE:DOW)

Receive News & Stock Ratings for Dow Chemical Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Company (The) and related stocks with our FREE daily email newsletter.